Re: FDNA Announces Collaboration with GeneDx and Blueprint Genetics in the Launch of Face2Gene LABS
"BTW there's a pumper on OPK today that concentrates on the non-essentials like Hollywood dress styles do"
You talking of the fool? Shoot, I didn't think the human growth thing did all this damage, did you?
You see the blurb from zacks, that fine analyst house that brought you the amazing concept that projected earnings increases are a good thing and they are the only ones that know it? (Did you know they have GALE as a #1 buy?*) Anyway, based upon implied volatility of the 6/16 $14 put, OPK is going to spike. Thats all they say.
*From a zacks earnings blurb
"Some better-ranked stocks in the health care sector are Infinity Pharmaceuticals, Inc. INFI, Galena Biopharma, Inc. GALE and BioTime, Inc. BTX. While Galena sports a Zacks Rank #1 (Strong Buy), BioTime and Infinity carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.